HTA Programmer (SAS/R) – German AMNOG, Remote/Hybrid

Duduo; Ávila; Híbrido; EUR 60.000 - 90.000; Jornada completa

Descripción de la vacante

IQVIA seeks a highly skilled Programmer (SAS & R) with German to support health technology assessment and market access initiatives from our Spain-based hybrid team. The role emphasizes statistical programming, data analysis, and automation across Module 4 analyses for German AMNOG dossiers.

The ideal candidate has >2 years in SAS programming, CDISC SDTM/ADaM, and fluent German and English. Collaboration with Market Access, HEOR, and EU-HTA teams is essential.

Formación

• Master's degree or PhD in biostatistics, data science, or related field.
• Experience in HTA, AMNOG, HEOR, or Market Access is preferred.
• Solid understanding of clinical study designs, endpoints, and statistical principles.
• Familiarity with CDISC SDTM/ADaM standards.

Responsabilidades

• Develop statistical analyses for Module 4 in German AMNOG dossiers.
• Analyze clinical trial data including efficacy and safety.
• Perform meta-analyses and indirect treatment comparisons.
• Automate analysis workflows for consistency and efficiency.
• Collaborate with Market Access, HEOR, Medical Affairs, and EU-HTA teams.
• Ensure quality and clarity of generated outcomes.
• Monitor IQWiG, G-BA methodologies and related HTA developments.

Conocimientos

SAS programming

R programming

CDISC SDTM/ADaM

Statistical programming

German language

English language

Data analysis

HTA/HEOR knowledge

Educación

Master's degree in biostatistics or data science

PhD (advantage)

Herramientas

SAS

R

Descripción del empleo

IQVIA seeks a highly skilled Programmer (SAS & R) with German to support health technology assessment and market access initiatives from our Spain-based hybrid team. The role emphasizes statistical programming, data analysis, and automation across Module 4 analyses for German AMNOG dossiers.

The ideal candidate has >2 years in SAS programming, CDISC SDTM/ADaM, and fluent German and English. Collaboration with Market Access, HEOR, and EU-HTA teams is essential.